Lv11
32 积分 2022-02-17 加入
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis
4小时前
已完结
The target atlas for antibody-drug conjugates across solid cancers
1个月前
已完结
TNF-like Ligand 1A (TL1A) Gene Knockout Leads to Ameliorated Collagen-Induced Arthritis in Mice: Implication of TL1A in Humoral Immune Responses
1个月前
已完结
Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model
2个月前
已关闭
T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases
2个月前
已完结
Ultrasound-responsive release of CD39 inhibitor overcomes adenosine-mediated immunosuppression in triple-negative breast cancer
3个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
3个月前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
3个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
3个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
3个月前
已完结
皖公网安备34019202002308
